Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment

RT @onechaintx: CAR-T therapy for solid tumors still faces major challenges due to… 1️⃣ Target diversity 2️⃣ Tumor heterogeneity  3️⃣  Com…

RT @onechaintx: CAR-T therapy for solid tumors still faces major challenges due to… 1️⃣ Target diversity 2️⃣ Tumor heterogeneity  3️⃣  Com…

https://t.co/C5QqJmIAyf

RT @onechaintx: CAR-T therapy for solid tumors still faces major challenges due to… 1️⃣ Target diversity 2️⃣ Tumor heterogeneity  3️⃣  Com…